|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at Deutsche Bank Securities Health Care Conference|
|BOULDER, Colo., Apr 26, 2002 /PRNewswire-FirstCall via COMTEX/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer,
Robert E. Conway, will speak at the Deutsche Bank Securities Health Care
Conference on May 9 in Baltimore, Maryland.
Event: Deutsche Bank Securities Health Care Conference Presentation by: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Thursday, May 9, 2002 Time: 12:30 p.m. Eastern Time Location: Baltimore Marriott Waterfront Webcast: www.arraybiopharma.comAbout Array BioPharma:
Array BioPharma is a drug discovery company inventing small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org